Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Journées Internationales de Biologie 2006

By Labmedica staff writers
Posted on 22 Dec 2006
The annual Journées Internationales de Biologie (JIB) was held November 7-10, 2006, in Paris (France) under the auspices of the French Ministère de la Santé et des Solidarités and the Caisse Nationale d'Assurance Maladie (CNAM). More...


This annual clinical biology meeting in Europe combined an expanding trade show with 165 confirmed exhibitors and a high-level scientific program that focused on state-of-the-art and current practices in the medical laboratory. Aimed at biologists in both the private and hospital sectors, biomedical engineers, technicians, and hospital physicians, JIB provided extensive and comprehensive information on progress and technical advances in clinical biology.

Tunisia was the invited guest country at the JIB 2006, succeeding Belgium, Spain, Portugal, and Italy. The opening ceremony of the exhibition was held at the Tunisian pavilion, the "Médina Ibn Khaldoun” in the presence of Dr. Mohamed Ridha Kechrid, minister of health of Tunisia, Tijani Haddad, minister of tourism of Tunisia, and Mohamed Raouf Najar, ambassador of Tunisia in Paris. During the opening address, Dr. Mohamed Ridha Kechrid underlined the strong links that have been established between France and Tunisia's biologists, giving as an example the successful collaboration of the "Bio Quality Tunisia.”

The "Scientific Day of Tunisia” retraced the history of medicine and biology in Tunisia and highlighted the medical specificities of the country. It also focused on the quality system at the National Blood Transfusion Center in Tunisia, and gave insight into gastric pathologies and Helicobacter pylori infections, as well as hemoglobinopathies in Tunisia.

This year, the scientific panel, traditionally composed of the Journées Biologiques de Lariboisière, the Société Française de Biologie Clinique (SFBC), and L'institut Nationale de la Santé et de la Recherche Médicale (INSERM), also consisted of the Journées de Internat des Hôpitaux de Paris (JIPPIF), the Société Française Vitamines et Biofacteurs (SFVB), and the Société Francophone d'Etude et de Recherche sur les Eléments Toxiques et Essentiels (SFERETE).

The scientific program, which consisted of 12 sessions, about 100 speakers, and 130 poster sessions, was attended by over 1,600 delegates. It offered a unique opportunity to become acquainted with state-of-the-art information about rare diseases. New subjects that are likely to influence future practices in biologic investigations, such as molecular imaging and apoptosis as well as more classical aspects of biology, were discussed.



Related Links:
Journées Internationales de Biologie

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.